Kevin Noonan

McDonnell Boehnen Hulbert & Berghoff LLP

Kevin Noonan is partner at McDonnell Boehnen Hulbert & Berghoff LLP and chair of the firm’s biotechnology and pharmaceuticals practice group.

Articles

NIST Proposes Clarifications to Bayh-Dole March-in Rights Regulations

Proposed changes to rules governing the commercialization of technologies developed with federal funding prompts significant stakeholder feedback.